• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Reducing the Use of Short-Acting Nifedipine by Hypertensives Using a Pharmaceutical Database
【24h】

Reducing the Use of Short-Acting Nifedipine by Hypertensives Using a Pharmaceutical Database

机译：使用药物数据库减少高血压患者使用短效硝苯地平

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: In view of the widespread concerns against prescribing short-acting nifedipine in the treatment of hypertension, the Veterans Health Administration initiated efforts to decrease the common but unapproved use of that agent for treating high blood pressure. Methods: A multitiered approach was implemented, using a national pharmaceutical database to assess drug utilization, followed by educational or remedial intervention at each tier. The first tier of the study determined the total quantity of short-acting nifedipine dispensed, the second tier evaluated data on the prescriptions for the drug, and the third and fourth tiers evaluated patient-specific information to determine to whom and why the drug was prescribed. Results: The first intervention demonstrated a 34 percent decrease in the total quantity of short- acting nifedipine dispensed, compared with the previous year. And action or change was noted in 78 percent of prescriptions in the second intervention. In the third intervention, short-acting nifedipine was prescribed for hypertension in 46.5 percent of the remaining 559 patients, 96 percent of which resulted in an intervention. The final intervention (75 patients) resulted in one prescribed short-acting nifedipine for hypertension under special circumstances. Conclusion: A tiered approach, using a national pharmaceutical database, complemented by local education and intervention, assisted in reducing the use of short-acting nifedipine for hypertension.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号